Fig. 2From: The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosisComparison of the therapeutic effect of UCMSCs between younger liver cirrhosis patients and older liver cirrhosis patients at different observation weeks. Group C: liver cirrhosis patients (age < 45 years); Group D: liver cirrhosis patients (age ≥ 45 years); TBIL total bilirubin. ***p < 0.01, **p < 0.05Back to article page